论文部分内容阅读
通过放射治疗原发于咽淋巴环的非何杰金淋巴瘤１２２例，结果表明，全组总的１，３，５，１０年生存率分别为６５．６％（８０／１２２），５９．８％（７３／１２２），５０．８％（６２／１２２），５８．５％（３１／５３）。病变部位、病理类型和性别、辅助化疗对疗效影响关系不大。全身症状、临床分期、肿瘤残存、照射剂量与预后关系密切，经统计学分析差异均有显著性（Ｐ＜０．０５）。治疗失败的主要原因是远处受侵，其次是原发灶局部复发。最常见的受侵部位是腹部，占复发及远处受侵病例的５１．１％（２３／４５）。
Radiotherapy of 122 cases of non-Hodgkin’s lymphoma originating in the pharyngeal lymph nodes showed that the overall 1,3,5-year and 10-year survival rates were 65.6% (80/122), 59 respectively. 8% (73/122), 50.8% (62/122), 58.5% (31/53). Lesions, pathological types and gender, adjuvant chemotherapy has little effect on the efficacy. Systemic symptoms, clinical stage, residual tumor, radiation dose and prognosis are closely related, the statistical analysis showed significant difference (P <0.05). The main reason for treatment failure is distant invasion, followed by local recurrence of the primary tumor. The most common site of invasion was the abdomen, accounting for 51.1% (23/45) of cases of recurrence and distant invasion.